Share on LinkedInShare on LinkedIn

ARTICLE · 24 MAY 2023

Antitrust & Competition Healthcare Quarterly Update Q1 2023

The DOJ withdrew long-standing antitrust healthcare policy statements that healthcare industry participants had relied on in crafting antitrust guidance, policies, and compliance programs for nearly three decades.

United StatesAntitrust/Competition Law

Summary

  • The DOJ withdrew long-standing antitrust healthcare policy statements that healthcare industry participants had relied on in crafting antitrust guidance, policies, and compliance programs for nearly three decades.
  • Despite scrutiny, the FTC declined to challenge Amazon's acquisition of One Medical but issued an unorthodox statement post-closing informing the parties "to be on notice" that the FTC will continue to closely monitor the parties' use of protected health information and warning that any violations could result in an enforcement action under Section 5 of the FTC Act.
  • The agencies continued appeals of high-profile matters even after novel theories of harm were rejected by lower-court judges. The FTC's disdain for Certificates of Public Advantage (COPAs) persists, resulting in one abandoned transaction and one pending litigation in both federal and state court.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from